DexCom, Inc. - Investor Relations At DexCom, Inc we promise to treat your data with respect and will not share your information with any third party You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below
DexCom, Inc. - Events Presentations By providing your email address below, you are providing consent to DexCom, Inc to send you the requested Investor Email Alert updates
DexCom, Inc. - Financials - Quarterly Results Conference Call Management will hold a conference call today starting at 4:30 p m (Eastern Time) The conference call will be concurrently webcast The link to the webcast will be available on the Dexcom Investor Relations website at investors dexcom com by navigating to “Events and Presentations,” and will be archived for future reference
DexCom, Inc. - Financials - Annual Reports Follow us IR Contacts Matt Carey Director, Investor Relations Joe Deltorchio Lead Investor Relations Manager (858) 200-0200 investor-relations@dexcom com
DexCom, Inc. - Dexcom to Host Investor Day on May 14, 2026 DexCom, Inc (NASDAQ:DXCM) today announced that it will host an Investor Day on Thursday, May 14, 2026 from 1:15 PM until approximately 3:30 PM PDT (4:15 PM – 6:30 PM EDT) The event will include presentations from Dexcom management highlighting the company’s market opportunities, business strategy, innovation efforts, and long-term financial outlook Links to a live webcast of the event
DexCom, Inc. - Dexcom Reports Second Quarter 2024 Financial Results . . . DexCom, Inc (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2024 Second Quarter 2024 Financial Highlights: Revenue grew 15% year-over-year to $1 004 billion on a reported basis and 16% year-over-year on an organic 1 basis U S revenue grew 19% and international revenue grew 7% on a reported basis and 10% on an organic 1 basis, all on a year-over
Dexcom Reports Third Quarter 2024 Financial Results DexCom, Inc (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2024 Third Quarter 2024 Financial Highlights: Revenue grew 2% year-over-year to $994 2 million on a reported basis and 3% year-over-year on an organic 1 basis U S revenue declined 2% and international revenue grew 12% on a reported basis and 16% on an organic 1 basis, all on a year
DexCom, Inc. - Dexcom Schedules First Quarter 2026 Earnings Release and . . . DexCom, Inc (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close on Thursday, April 30, 2026 Management will hold a conference call to review the company's first quarter 2026 performance starting at 4:30 p m (Eastern Time) on the same day The conference call will be concurrently webcast The link to the webcast will be available
DexCom, Inc. - Dexcom Reports Third Quarter 2025 Financial Results and . . . DexCom, Inc (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2025 Third Quarter 2025 Financial Highlights: Revenue grew 22% year-over-year to $1 209 billion on a reported basis and 20% year-over-year on an organic 1 basis U S revenue grew 21% and international revenue grew 22% on a reported basis and 18% on an organic 1 basis, all on a year
Dexcom Reports First Quarter 2026 Financial Results DexCom, Inc (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2026 First Quarter 2026 Financial Highlights: Revenue grew 15% year-over-year to $1 192 billion on a reported basis and 12% year-over-year on an organic 1 basis U S revenue grew 11% and international revenue grew 26% on a reported basis and 17% on an organic 1 basis, all on a year-over